139 results on '"Collen, Desire"'
Search Results
2. Duodenal Calcium Absorption in Vitamin D Receptor-Knockout Mice: Functional and Molecular Aspects
3. The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin: Implications for Antiangiogenic Strategies
4. Long-Term Expression of Human Coagulation Factor VIII and Correction of Hemophilia A after in vivo Retroviral Gene Transfer in Factor VIII-Deficient Mice
5. Receptor-Independent Role of Urokinase-Type Plasminogen Activator in Pericellular Plasmin and Matrix Metalloproteinase Proteolysis during Vascular Wound Healing in Mice
6. Urokinase-Type Plasminogen Activator is Effective in Fibrin Clearance in the Absence of its Receptor or Tissue-Type Plasminogen Activator
7. Placental growth factor 2 — A potential therapeutic strategy for chronic myocardial ischemia
8. Sustained Placental Growth Factor-2 Treatment Does Not Aggravate Advanced Atherosclerosis in Ischemic Cardiomyopathy
9. Emerging treatments for thrombocytopenia: Increasing platelet production
10. Cardioselective nitric oxide synthase 3 gene transfer protects against myocardial reperfusion injury
11. Role of Gas6 in erythropoiesis and anemia in mice
12. A genetic Xenopus laevis tadpole model to study lymphangiogenesis
13. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
14. VEGF: A modifier of the del22q11 (DiGeorge) syndrome?
15. Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor
16. Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome
17. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
18. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis
19. Collaborative Angiographic Patency Trial of Recombinant Staphylokinase (CAPTORS)
20. Specific proteolysis of human plasminogen by a 24 kDa endopeptidase from a novel Chryseobacterium sp
21. Impaired myocardial angiogenesis and eschemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF(sub.164) and VEGF(sub.188)
22. Genetic evidence for a tumor suppressor role of HIF-2α
23. Role of HIF-1-alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
24. Arginine 719 in human plasminogen mediates formation of the staphylokinase:plasmin activator complex
25. Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial
26. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding
27. Molecular analysis of blood vessel formation and disease
28. Randomized coronary patency trial of double-bolus recombinant staphylokinase versus front-loaded alteplase in acute myocardial infarction
29. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
30. Clot-Selective Coronary Thrombolysis with Tissue-Type Plasminogen Activator
31. Phospholipid binding of lecithin-cholesterol acyltransferase activation properties of apolipoprotein A-I mutants
32. Physiological consequences of loss of plasminogen activator gene function in mice
33. Toxicology Studies with Recombinant Staphylokinase and with SY 161-P5, a Polyethylene Glycol-Derivatized Cysteine-Substitution Mutant
34. Humoral immune response in mice against a circulating antigen induced by adenoviral transfer is strictly dependent on expression in antigen-presenting cells
35. Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors
36. Clinical development of PEGylated recombinant staphylokinase (PEG–Sak) for bolus thrombolytic treatment of patients with acute myocardial infarction
37. Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo
38. Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia
39. Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model
40. Role of tissue factor in embryonic blood vessel development
41. Depletion of circulating α2-antiplasmin by intravenous plasmin or immunoneutralization reduces focal cerebral ischemic injury in the absence of arterial recanalization
42. Recombinant staphylokinase variants with reduced antigenicity due to elimination of B-lymphocyte epitopes
43. Circulating Activated Platelets Assist THP-1 Monocytoid/Endothelial Cell Interaction Under Shear Stress
44. Structure-Function Analyses of Thrombomodulin by Gene-Targeting in Mice: The Cytoplasmic Domain Is Not Required for Normal Fetal Development
45. Involvement of Sp1 in basal and retinoic acid induced transcription of the human tissue-type plasminogen activator gene
46. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
47. Malondialdehyde-Modified LDL as a Marker of Acute Coronary Syndromes
48. Sustained Endothelial Progenitor Cell Dysfunction After Chronic Hypoxia-Induced Pulmonary Hypertension.
49. Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling.
50. Microplasmin reduces ischemic brain damage and improves neurological function in a rat stroke model monitored with MRI.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.